A Phase II, Multicenter, Randomized, Single-Masked, Sham-Controlled Study of Safety, Tolerability and Evidence of Activity of Intravitreal APL-2 Therapy in Patients Geographic Atrophy (GA) - FILLY
Clinical Trial Grant
Administered By
Ophthalmology
Awarded By
Apellis Pharmaceuticals, Inc
Start Date
August 1, 2015
End Date
May 31, 2019
Administered By
Ophthalmology
Awarded By
Apellis Pharmaceuticals, Inc
Start Date
August 1, 2015
End Date
May 31, 2019